Reduced Health Related Quality of Life, Increased Fatigue, and Daytime Sleepiness in Women with Hyperprolactinemia
Hormone and Metabolic Research · 23.02.2023
DOI: 10.1055/a-2042-0712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 23.02.2023. Verfasst von Åsa Ernersson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health, Medicine and Caring Sciences, Division of Nursing Science and Reproductive Health, Linköping University, Linköping, Sweden. Hauptthemen laut MEDLINE: Hyperprolactinemia, Disorders of Excessive Somnolence. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Forskningsrådet i Sydöstra Sverige.
Abstract (Originalsprache)
Prolactin has many physiological effects and seems to be involved in the human quality of life and well-being. The aim of this study was to describe health related quality of life, fatigue and daytime sleepiness in women with untreated hyperprolactinemia. In total 32 women (mean age 37.0±10.9 years) with verified hyperprolactinemia completed a questionnaire including questions on fatigue, measured with the Swedish version of the Fatigue Impact Scale (FIS), propensity to fall in sleep, measured with the Swedish version of the Epworth Sleepiness Scale (ESS), and Health related quality of life (HRQoL), measured by the Short-Form-36 scale (SF-36). For comparison Swedish normative data were used. The women were also interviewed regarding different symptoms related to hyperprolactinemia and the answers were analyzed using qualitative content analysis. HRQoL, as measured with SF-36, was significantly lower in all dimensions, except in physical function, compared to the Swedish reference population. Total FIS was 54.3 (41.1) and mean score on the ESS was 8.7 (4.2) indicating increased fatigue and deterioration in night sleep. The women felt very tired, and several of them rarely felt rested in the morning. The restless night sleep and the fatigue during the daytime got them to feel feeble and sometimes to find it difficult to concentrate, which affected both their mood and life in general. Women diagnosed with hyperprolactinemia reported deterioration in night sleep, increased rate of fatigue, and a reduced health related quality of life in comparison with the reference population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Health, Medicine and Caring Sciences, Division of Nursing Science and Reproductive Health, Linköping University, Linköping, Sweden.
- Department of Clinical Chemistry and Department of Clinical and Experimental Medicine, Linköping University, Linkoping, Sweden.
- Department of Endocrinology and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
- Faculty of Medical Sciences, Örebro University, Örebro, Sweden.
ORCID-Profile: Åsa Ernersson, Bertil Ekman, Jeanette Wahlberg
Förderung
- Forskningsrådet i Sydöstra Sverige
Zitieren
APA
Ernersson, Å., Bachrack-Lindström, M., Landberg, E., Ekman, B., & Wahlberg, J. (2023). Reduced Health Related Quality of Life, Increased Fatigue, and Daytime Sleepiness in Women with Hyperprolactinemia. Hormone and Metabolic Research. https://doi.org/10.1055/a-2042-0712
Vancouver
Ernersson Å, Bachrack-Lindström M, Landberg E, Ekman B, Wahlberg J. Reduced Health Related Quality of Life, Increased Fatigue, and Daytime Sleepiness in Women with Hyperprolactinemia. Hormone and Metabolic Research. 2023. doi:10.1055/a-2042-0712
BibTeX
@article{Ernersson2023,
author = {Ernersson, Åsa and Bachrack-Lindström, Margareta and Landberg, Eva and Ekman, Bertil and Wahlberg, Jeanette},
title = {Reduced Health Related Quality of Life, Increased Fatigue, and Daytime Sleepiness in Women with Hyperprolactinemia},
journal = {Hormone and Metabolic Research},
year = {2023},
doi = {10.1055/a-2042-0712}
}
EUVIMED